Antiviral compositions

Details Antiviral compositions Antiviral compositions

2007-07-10

2007-07-10

Padmanabhan, Sreeni (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S484000, C424S464000, C424S497000, C424S486000, C514S272000, C514S274000, C514S275000, C544S323000, C544S321000, C544S320000

Reexamination Certificate

active

10088805

ABSTRACT:
The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

REFERENCES:
patent: 2671810 (1954-03-01), Coffman et al.
patent: 2742466 (1956-04-01), Randall et al.
patent: 4096206 (1978-06-01), Boyer
patent: 4450162 (1984-05-01), Kamioka et al.
patent: 4652645 (1987-03-01), Stingelin et al.
patent: 4659363 (1987-04-01), Hubele et al.
patent: 5017466 (1991-05-01), Kobayasji et al.
patent: 5574040 (1996-11-01), Bukrinsky et al.
patent: 5716722 (1998-02-01), Hamada et al.
patent: 5837436 (1998-11-01), Mihayashi et al.
patent: 5939099 (1999-08-01), Grabowski et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6197779 (2001-03-01), Andries et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: 2 038 182 (1972-02-01), None
patent: 26 11 826 (1976-09-01), None
patent: 0 145 656 (1985-05-01), None
patent: 0 270 111 (1988-06-01), None
patent: 0 541 966 (1993-05-01), None
patent: 0 588 762 (1994-03-01), None
patent: 0 795 549 (1997-09-01), None
patent: 0 834 507 (1998-04-01), None
patent: 0 872 233 (1998-10-01), None
patent: 0872233 (1998-10-01), None
patent: 0 945 443 (1999-09-01), None
patent: 0 945 447 (1999-09-01), None
patent: 2099730 (1972-03-01), None
patent: 2 398 740 (1979-03-01), None
patent: 2 400 535 (1979-04-01), None
patent: 1 010 998 (1965-11-01), None
patent: 1 477 349 (1977-06-01), None
patent: 211 774 (1995-12-01), None
patent: 02 052 360 (1990-02-01), None
patent: 2-286666 (1990-11-01), None
patent: 02 300 264 (1990-12-01), None
patent: 08 199 163 (1996-08-01), None
patent: 09 068 784 (1997-03-01), None
patent: 11-116555 (1999-04-01), None
patent: 143 808 (1962-01-01), None
patent: 91/18887 (1991-12-01), None
patent: WO 94/00513 (1994-01-01), None
patent: WO 94/02470 (1994-02-01), None
patent: 95/10506 (1995-04-01), None
patent: WO 95/15952 (1995-06-01), None
patent: WO 97/10887 (1997-03-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 98/41512 (1998-09-01), None
Ashley et al., “The Search for Chemotherapeutic Amidines. Part XVI. Amidinoanilino-1,3,5-triazines and Related Compounds,”J. Chem. Soc.,Jan. 1, 1960, 4525-4532.
Koyanagi et al., “Selective Cytotoxicity of Aids Virus Infection Towards HTLV-1-Transformed Cell Lines,”Int. J. Cancer, 1985, 36, 445-451.
Martindale,The Extra Pharmacopoeia, 29thedition, p. 1435.
Prakash, L. et al, “Synthesis of some new trisubstituted derivatives of 2,4,6-trichloro-1,3,5-triazine and their anti-bacterial activity,”Pharmazie, 1990, 45(4), 284.
Ghosh, D. et al., “2,4-Bis(arylamino)-5-methylpyrimidines as Antimicrobial Agents,”J. Med. Chem., 1969, 10, 974-975.
Chen, C., “Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor Receptor Antagonists,”J. Med. Chem., 1996, 39(22), 4358-4360.
International Search Report issued in International Application No. PCT/EP00/08522, Date of Mailing: Jan. 2, 2001.
J. W. F. McOmie (ed.),Protective Groups in Organic Chemistry, Plenum Press, 1973.
T. W. Greene & P. G. M. Wutz (eds.),Protective Groups in Organic Synthesis, 2ndedition, Wiley Interscience, 1991, pp. 473.
CRC Handbook, 64thedition, p. F-114.
Shaihla, M. et al., “Synthesis of some new fluorinated derivatives of 1,3,5-triazine as potential biologically active agents,” Chem. Abstr., 1990, 112(1), abstract No. 7458v, p. 733.
Kreutzberger, A. et al., “Anticonvulsives. IV. 2,4,6- mixed functional substituted 1,3,5-triazines,” Chem. Abstr., 1988, 108(15), abstract No. 131766a, p. 752.
Langalia, N. A. et al., “Studies on antitubercular agents. Part III. Preparation of some p-(2,4-diarylamino-6-S-triazinylamino)-benzaldehyde/acetophenone thiosemicarbazones as potential tuberculostatic agents,” Chem. Abstr., 1983, 98(11), abstract No. 89321z, p. 556.
Unishi, T. et al., “Preparation of polypyromellitimides containing dialkylamino-type melamine units,” Chem. Abstr., 1981, 95(4), 25685b, p. 3.
Ghosh, D., “2,4-Bis(arylamino)-6-methylpyrimidines as antimicrobial agents,” Chem. Abstr. 1981, 95(11), 97712f, p. 648.
Parekh, H. et al., “Optically active s-triazine derivatives. I. Preparation of D(×)-2,4-diarylamino-6-α-carboxybenzylamino-s-triazines,” Chem. Abstr., 1975, 83(23), 193239e, p. 460.
Acharya, J.N. et al., Studies ons-Triazinyl Compounds as Potential Medicinal Agents. Part I,J. Indian Chem. Soc., Feb. 1976, vol. LII, 1190-1192.
Acharya, J.N. et al., Studies ons-Triazinyl Compounds as Potential Medicinal Agents. Part II,J. Indian Chem. Soc., Feb. 1976, vol. LIII, 193-195.
Arutyunyan, E.A. et al., “Reaction of Uracils with Phosphoric Acid Amides”,Institute Org., Khim. Im Zelinskogo. IZV. Akad. Nauk SSSR, Ser Khim., 1970, 4, 904-909 English language abstract provided.
Fernandes, Y., et al., “Studies ons-Triazine Part VI: 2,4-Bisalyklamino 6 (Phenyl Azoaryl Hydrazino)-s-Triazine”,J. Inst. Chemists(India), May 1991, 63, 103-104.
Campbell, J.R. et al., “Unsymmetrically Substituted Melamines”,J. Org. Chem., 1961, 26, 2786-2789.
Chen, C. et al., “Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor 1 Receptor Antagonists”,J. Med. Chem., 1996, 39, 4358-4360.
Freiberg, R. et al., “Synthese von 2,4-Bisalkyl(aryl)amino-6-Cyanamino-1,3,5-Triazinen”,J. Prakt. Chem, 1985, 327(3), 471-478.
Ghosh, D., “2,4-Bis (Arylamino)-6-Methyl Pyrimidines as Antimicrobial Agents”,J. Indian Chem. Soc., May 1981, vol. LVIII, 512-513.
Ghosh, D., “2,4-Bis(Arylamino)Pyrimidines as Antimicrobial Agents”,J. Med Chem., 1966, 9(3), 423-424.
Ghosh, D. et al., “2,4 Bis(p-Chloroanilino)-Pyrimidine, an Uncoupler of Oxidative Phosphorylation”FEBS Letters, 4(3), 157-159.
Ghosh, D. et al., “2,4-Bis(arylamino)-5-Methylpyrimidines as Antimicrobial Agents”,J. Med. Chem., 1967, 10(5), 974-975.
Ghoneim, K.M. et al., “Synthesis and Evaluation of Some 2,4 and 2,4-Disubstituted-6-Methylpyrimidine Derivatives for Antimicrobial Activity”,Egypt J. Pharm Sci., 1978, 28(1-4), 117-126.
Goghari, M.H. et al., “Studies on s-Triazinyl Aryl/Alkyl Sulphones. Part 1, Preparation of 4′(2-p-Chlorophenylsulphonyl-4- Aryl/Alkyl Amino-s-Triazin-6-yl)-Aminobenzoic Acid”,J. Indian Chem Soc., 1976, 53(2), 207-208.
Goghari, M.H. et al., Studies ons-Triazinyl Aryl/Alkyl Sulphones Part-III,Def Sci J.,1977, 27(3), 141-144.
Inoue, et al, “Synthesis of 2-(p-Aminophenyiazo)-1,3,5-Triazine Derivatives”,Nippon Kagaku Kaishi, 1981, 12, 1922-1928 (English Abstract).
Kamdar, G.C. et al., “Preparation and Antibacterial Activity of 2-Phenyl-3-(2′, 4′-Diarylamino-s-Triazin-6-yl)-5/H/Ch3-Carboxymethyl-4-thiazolidinone and 2-Aryl-3-(p-Aminosulphophenyl/2′-Pyrimidylaminosulphopheynyl)-p-Carboxymethyl-4-Thiazolidinones”,J. Indian Chem. Soc., May 1987, vol. LXIV, 298-301.
Inoue, Y. et al., “Synthesis ofp-Nitrophenylazo-s-Triazines”,Yuki Gosei Kagaku Kyokaishi, 1978, 36(9), 779-793.
Honda, I., “Synthesis of Arylmelamines. II. Synthesis of Diarymelamines”,Yuki Gosei Kagaku Kyokaishi, 1962, 20, 460-465 (English Abstract).
London Rubber Industries Ltd.'s Patent(Manner of Manufacture P.A.T.), Reports of Patent, Design and Trademark Cases, 1968, In the Appeal TribunalBeforeR. Justice Lloyd-Jacob, 31-35.
L'Oreal's Application, Patent Appeal Tribunal, 1970, 20, R.P.C., In the Appeal TribunalBefore: Mr. Justice Graham and Mr. Justice Whitford, 565-573.
Ghoneim, et al., “Synthesis and Evaluation of some 2-,4- and 2, 4-di-substituted-6-Methylpyrimidine Derivatives for Antimicrobial Activity&

Affiliated with

Also associated with

Rating

Antiviral compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3799008